Endoscopic Vessel Harvesting Global Market to 2027 Insight: Featuring Cardio Medical, Karl Storz and Terumo Among Others

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Endoscopic Vessel Harvesting Global Market Trajectory & Analytics report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Endoscopic Vessel Harvesting estimated at US$456.3 Million in the year 2020, is projected to reach a revised size of US$580.9 Million by 2027, growing at a CAGR of 3.5% over the analysis period 2020-2027.

EVH Systems, one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$293.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Endoscopes segment is readjusted to a revised 3.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $134.2 Million, While China is Forecast to Grow at 3.3% CAGR

The Endoscopic Vessel Harvesting market in the U.S. is estimated at US$134.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$103.4 Million by the year 2027 trailing a CAGR of 3.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 2.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Accessories Segment to Record 2.9% CAGR

In the global Accessories segment, USA, Canada, Japan, China and Europe will drive the 3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$62.5 Million in the year 2020 will reach a projected size of US$77 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$64.7 Million by the year 2027.

Select Competitors (Total 40 Featured):

  • Cardio Medical
  • Getinge
  • Karl Storz
  • Livanova
  • MAQUET Holding B.V. & Co. KG
  • Med Europe S.r.l. (Elite Life Care)
  • Medical Instruments Spa
  • Saphena Medical
  • Terumo

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 40

For more information about this report visit here.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles